Veterinary Pharmaceutical Supply – Butorphanol Tartrate Injection

The contract solicits the supply of 19 units of Butorphanol Tartrate Injection, Veterinary, 10 mg/mL in 50 mL vials, a DEA Schedule IV controlled substance intended for pain management in adult horses and yearlings. The product is classified as a veterinary pharmaceutical and must comply with all federal regulations governing controlled substances, including secure handling, labeling, and distribution protocols. The requirement is issued as a subcontract under the NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, indicating the need for a qualified manufacturer or distributor with expertise in regulated veterinary pharmaceuticals. The solicitation was posted on May 10, 2026, with responses due by May 18, 2026, and the place of performance is designated as APO, 09227-0000, suggesting delivery to a U.S. military installation overseas. The contracting organization is the Medical Supply Chain Pharm FSA under the Department of Defense, underscoring the defense-related veterinary needs of equine assets used in military operations. Compliance with controlled substance regulations, timely delivery, and adherence to military procurement standards are critical to fulfillment, though no specific set-aside provisions or point of contact details are provided in the data.